Aroa Biosurgery (Australia) Performance
| ARX Stock | 0.49 0.01 2.08% |
The firm shows a Beta (market volatility) of 0.41, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aroa Biosurgery's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aroa Biosurgery is expected to be smaller as well. At this point, Aroa Biosurgery has a negative expected return of -0.37%. Please make sure to confirm Aroa Biosurgery's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Aroa Biosurgery performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Aroa Biosurgery has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 8.8 M |
Aroa |
Aroa Biosurgery Relative Risk vs. Return Landscape
If you would invest 65.00 in Aroa Biosurgery on December 13, 2024 and sell it today you would lose (16.00) from holding Aroa Biosurgery or give up 24.62% of portfolio value over 90 days. Aroa Biosurgery is producing return of less than zero assuming 4.201% volatility of returns over the 90 days investment horizon. Simply put, 37% of all stocks have less volatile historical return distribution than Aroa Biosurgery, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aroa Biosurgery Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aroa Biosurgery's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aroa Biosurgery, and traders can use it to determine the average amount a Aroa Biosurgery's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0892
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARX |
Estimated Market Risk
| 4.2 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aroa Biosurgery is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aroa Biosurgery by adding Aroa Biosurgery to a well-diversified portfolio.
Aroa Biosurgery Fundamentals Growth
Aroa Stock prices reflect investors' perceptions of the future prospects and financial health of Aroa Biosurgery, and Aroa Biosurgery fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aroa Stock performance.
| Return On Equity | -0.0805 | ||||
| Return On Asset | -0.0567 | ||||
| Profit Margin | (0.1) % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 150.53 M | ||||
| Shares Outstanding | 345.93 M | ||||
| Price To Book | 1.94 X | ||||
| Price To Sales | 2.24 X | ||||
| Revenue | 63.36 M | ||||
| EBITDA | (7.36 M) | ||||
| Total Debt | 6.82 M | ||||
| Book Value Per Share | 0.27 X | ||||
| Cash Flow From Operations | (6.76 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Total Asset | 101.88 M | ||||
| Retained Earnings | (56.98 M) | ||||
About Aroa Biosurgery Performance
Assessing Aroa Biosurgery's fundamental ratios provides investors with valuable insights into Aroa Biosurgery's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Aroa Biosurgery is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Things to note about Aroa Biosurgery performance evaluation
Checking the ongoing alerts about Aroa Biosurgery for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aroa Biosurgery help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aroa Biosurgery generated a negative expected return over the last 90 days | |
| Aroa Biosurgery has some characteristics of a very speculative penny stock | |
| Aroa Biosurgery has high historical volatility and very poor performance | |
| The company reported the revenue of 63.36 M. Net Loss for the year was (9.75 M) with profit before overhead, payroll, taxes, and interest of 66.15 M. | |
| Aroa Biosurgery generates negative cash flow from operations | |
| About 26.0% of the company shares are held by company insiders |
- Analyzing Aroa Biosurgery's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aroa Biosurgery's stock is overvalued or undervalued compared to its peers.
- Examining Aroa Biosurgery's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aroa Biosurgery's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aroa Biosurgery's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aroa Biosurgery's stock. These opinions can provide insight into Aroa Biosurgery's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Aroa Stock Analysis
When running Aroa Biosurgery's price analysis, check to measure Aroa Biosurgery's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aroa Biosurgery is operating at the current time. Most of Aroa Biosurgery's value examination focuses on studying past and present price action to predict the probability of Aroa Biosurgery's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aroa Biosurgery's price. Additionally, you may evaluate how the addition of Aroa Biosurgery to your portfolios can decrease your overall portfolio volatility.